It Takes Two to Tango: The Structure and Function of LIM, RING, PHD and MYND Domains
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3681-3696
Author(s):
J. M. Matthews, M. Bhati, E. Lehtomaki, R. E. Mansfield, L. Cubeddu and J. P. Mackay
Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3697-3715
Author(s):
Helen C. Ardley
Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
968-985
Author(s):
Andreas Faust, Sven Hermann, Stefan Wagner, Gunther Haufe, Otmar Schober, Michael Schafers and Klaus Kopka
Molecular Imaging of Apoptosis with Radio-Labeled Annexin A5 Focused on the Evaluation of Tumor Response to Chemotherapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
1003-1011
Author(s):
Yuji Kuge, Songji Zhao, Toshiki Takei and Nagara Tamaki
Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
1024-1038
Author(s):
Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada
Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3782-3795
Author(s):
Wei Zhang and M. Eileen Dolan
The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
243-255
Author(s):
Hanne Fredly, Elisabeth Ersvaer, Camilla Stapnes, Bjorn Tore Gjertsen and Oystein Bruserud
Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
303-309
Author(s):
Junya Kuroda and Masafumi Taniwaki
Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
854-870
Author(s):
P. Tassone, P. Tagliaferri, M. Rossi, T. Calimeri, A. Bulotta, A. Abbruzzese, M. Caraglia and P. Neri
Association of p53 with Bid Induces Cell Death in Response to Etoposide Treatment in Hepatocellular Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
871-880
Author(s):
G. Song, G. G. Chen, J.-P. Yun and P. B.S. Lai